Literature DB >> 27492254

Microfluidics: a transformational tool for nanomedicine development and production.

Shyam Garg1, Gesine Heuck1, Shell Ip1, Euan Ramsay1.   

Abstract

Microfluidic devices are mircoscale fluidic circuits used to manipulate liquids at the nanoliter scale. The ability to control the mixing of fluids and the continuous nature of the process make it apt for solvent/antisolvent precipitation of drug-delivery nanoparticles. This review describes the use of numerous microfluidic designs for the formulation and production of lipid nanoparticles, liposomes and polymer nanoparticles to encapsulate and deliver small molecule or genetic payloads. The advantages of microfluidics are illustrated through examples from literature comparing conventional processes such as beaker and T-tube mixing to microfluidic approaches. Particular emphasis is placed on examples of microfluidic nanoparticle formulations that have been tested in vitro and in vivo. Fine control of process parameters afforded by microfluidics, allows unprecedented optimization of nanoparticle quality and encapsulation efficiency. Automation improves the reproducibility and optimization of formulations. Furthermore, the continuous nature of the microfluidic process is inherently scalable, allowing optimization at low volumes, which is advantageous with scarce or costly materials, as well as scale-up through process parallelization. Given these advantages, microfluidics is poised to become the new paradigm for nanomedicine formulation and production.

Entities:  

Keywords:  Liposomes; RNAi; microfluidic mixing; nanoparticles; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27492254     DOI: 10.1080/1061186X.2016.1198354

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

Review 1.  Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.

Authors:  Qingxin Mu; Jesse Yu; Lisa A McConnachie; John C Kraft; Yu Gao; Gaurav K Gulati; Rodney J Y Ho
Journal:  J Drug Target       Date:  2018-01-10       Impact factor: 5.121

2.  Microfluidic synthesis of protein-loaded nanogels in a coaxial flow reactor using a design of experiments approach.

Authors:  Zoe Whiteley; Hei Ming Kenneth Ho; Yee Xin Gan; Luca Panariello; Georgios Gkogkos; Asterios Gavriilidis; Duncan Q M Craig
Journal:  Nanoscale Adv       Date:  2021-02-18

Review 3.  Microfluidic formulation of nanoparticles for biomedical applications.

Authors:  Sarah J Shepherd; David Issadore; Michael J Mitchell
Journal:  Biomaterials       Date:  2021-04-26       Impact factor: 15.304

4.  Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.

Authors:  Andrew Gdowski; Kaitlyn Johnson; Sunil Shah; Ignacy Gryczynski; Jamboor Vishwanatha; Amalendu Ranjan
Journal:  J Nanobiotechnology       Date:  2018-02-12       Impact factor: 10.435

5.  Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures.

Authors:  Sarah Streck; Henriette Neumann; Hanne Mørck Nielsen; Thomas Rades; Arlene McDowell
Journal:  Int J Pharm X       Date:  2019-08-13

6.  Excipient-Free Pure Drug Nanoparticles Fabricated by Microfluidic Hydrodynamic Focusing.

Authors:  Roni Sverdlov Arzi; Asaf Kay; Yulia Raychman; Alejandro Sosnik
Journal:  Pharmaceutics       Date:  2021-04-10       Impact factor: 6.321

Review 7.  High Frequency Sonoprocessing: A New Field of Cavitation-Free Acoustic Materials Synthesis, Processing, and Manipulation.

Authors:  Amgad R Rezk; Heba Ahmed; Shwathy Ramesan; Leslie Y Yeo
Journal:  Adv Sci (Weinh)       Date:  2020-11-23       Impact factor: 16.806

8.  Improving Antibacterial Activity of a HtrA Protease Inhibitor JO146 against Helicobacter pylori: A Novel Approach Using Microfluidics-Engineered PLGA Nanoparticles.

Authors:  Jimin Hwang; Sonya Mros; Allan B Gamble; Joel D A Tyndall; Arlene McDowell
Journal:  Pharmaceutics       Date:  2022-02-01       Impact factor: 6.321

9.  A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines.

Authors:  Ana Casadó; M Lluïsa Sagristá; Margarita Mora
Journal:  Int J Nanomedicine       Date:  2018-09-11

Review 10.  Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.

Authors:  Mohamed Haider; Shifaa M Abdin; Leena Kamal; Gorka Orive
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.